{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:43Z","timestamp":1787070883446,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The study was done to evaluate the role of adjuvant therapy in curatively resected Stage II and III gallbladder carcinoma (GBC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This was a retrospective analysis of patients of GBC registered between 2008 and 2017 in outpatient department of a tertiary cancer hospital in India. Patients who had any of the following adjuvant treatment after radical surgery: (a) external beam radiotherapy (RT) alone, (b) chemotherapy (CT) alone, and (c) RT with CT (CRT) were considered for the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of fifty patients could meet the selection criteria. It was seen that seven patients were treated with RT, 20 with CT, and 23 with CRT. Median follow-up for patients who were alive was 26.7 months. Nineteen patients had locoregional failure while eight had distant failure. Patients treated with CRT had a significantly better mean overall survival compared to those treated with RT or CT (44.0 months, 12.5 months, and 15.1 months, respectively;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003). Similarly, mean disease-free survival was superior in CRT arm compared to RT and CT arms (43.6 months, 9.6 months, and 12.4 months, respectively;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Adjuvant CRT had better survival outcome compared to patients treated with either RT or CT with Stage II and III disease after curative cholecystectomy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_550_19","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T06:55:45Z","timestamp":1603868145000},"page":"1064-1068","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Influence of adjuvant therapy on pattern of failure and survival in curatively resected gallbladder carcinoma"],"prefix":"10.4103","volume":"17","author":[{"given":"Sunil","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Prakash","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avipsa","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit Mohan","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallika","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam Kumar","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-38-20241021","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3857\/roj.2017.00388","article-title":"Patterns of initial failure after resection for gallbladder cancer: Implications for adjuvant radiotherapy","volume":"35","author":"Kim","year":"2017","journal-title":"Radiat Oncol J"},{"key":"R2-38-20241021","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12885-015-1617-y","article-title":"Adjuvant therapy in the treatment of gallbladder cancer: A meta-analysis","volume":"15","author":"Ma","year":"2015","journal-title":"BMC Cancer"},{"key":"R3-38-20241021","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"R4-38-20241021","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1200\/JCO.2007.14.7934","article-title":"Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer","volume":"26","author":"Wang","year":"2008","journal-title":"J Clin Oncol"},{"key":"R5-38-20241021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1245\/s10434-017-6139-1","article-title":"Adjuvant chemoradiotherapy is associated with improved survival for patients with resected gallbladder carcinoma: A systematic review and meta-analysis","volume":"25","author":"Kim","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R6-38-20241021","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1200\/JCO.2010.33.8020","article-title":"Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer","volume":"29","author":"Wang","year":"2011","journal-title":"J Clin Oncol"},{"key":"R7-38-20241021","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/SLA.0000000000002385","article-title":"Surgical management of gallbladder cancer: Simple versus extended cholecystectomy and the role of adjuvant therapy","volume":"266","author":"Kasumova","year":"2017","journal-title":"Ann Surg"},{"key":"R8-38-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw324","article-title":"Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival","volume":"109","author":"Mitin","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R9-38-20241021","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/cncr.30968","article-title":"The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts","volume":"124","author":"Tran Cao","year":"2018","journal-title":"Cancer"},{"key":"R10-38-20241021","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0360-3016(01)01764-3","article-title":"Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma","volume":"52","author":"Kresl","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-38-20241021","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijrobp.2008.10.052","article-title":"Adjuvant therapy for gallbladder carcinoma: The mayo clinic experience","volume":"75","author":"Gold","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-38-20241021","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ijrobp.2004.12.059","article-title":"Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: A 23-year experience","volume":"62","author":"Czito","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-38-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw202","article-title":"Adjuvant therapy for resected gallbladder cancer: Analysis of the national cancer data base","volume":"109","author":"Mantripragada","year":"2017","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_550_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:12Z","timestamp":1787067492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_550_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_550_19","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}